Integer Holdings Corporation (ITGR) Hit a 52 Week High, Can the Run Continue?
https://www.zacks.com/stock/news/2197283/integer-holdings-corporation-itgr-hit-a-52-week-high-can-the-run-continue?cid=CS-ZC-FT-52_week_high-2197283
Dec 13, 2023 - Integer (ITGR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
0
Why Integer (ITGR) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2198672/why-integer-itgr-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2198672
Dec 15, 2023 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
Reasons to Add DexCom (DXCM) Stock to Your Portfolio Now
https://www.zacks.com/stock/news/2199515/reasons-to-add-dexcom-dxcm-stock-to-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2199515
Dec 18, 2023 - DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
0
ITGR or EW: Which Is the Better Value Stock Right Now?
https://www.zacks.com/stock/news/2199504/itgr-or-ew-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2199504
Dec 18, 2023 - ITGR vs. EW: Which Stock Is the Better Value Option?
0
Here's Why You Should Retain QuidelOrtho (QDEL) Stock for Now
https://www.zacks.com/stock/news/2199972/here-s-why-you-should-retain-quidelortho-qdel-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2199972
Dec 19, 2023 - QuidelOrtho's (QDEL) strong product portfolio raises optimism about the stock.
0
Reasons to Retain Cencora (COR) Stock in Your Portfolio for Now
https://www.zacks.com/stock/news/2201400/reasons-to-retain-cencora-cor-stock-in-your-portfolio-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2201400
Dec 22, 2023 - Cencora (COR) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
0
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
https://www.zacks.com/stock/news/2202089/reasons-to-retain-pacbio-pacb-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2202089
Dec 26, 2023 - PacBio's (PACB) product development activities raise optimism about the stock.
0
Microbot Medical (MBOT) Announces Positive GLP Study Results
https://www.zacks.com/stock/news/2205065/microbot-medical-mbot-announces-positive-glp-study-results?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2205065
Jan 03, 2024 - Microbot Medical's (MBOT) latest favorable study results are likely to support its IDE submission to the FDA to commence its human clinical study.
0
ITGR vs. EW: Which Stock Should Value Investors Buy Now?
https://www.zacks.com/stock/news/2205153/itgr-vs-ew-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2205153
Jan 03, 2024 - ITGR vs. EW: Which Stock Is the Better Value Option?
0
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
https://www.zacks.com/stock/news/2205238/reasons-to-retain-quest-diagnostics-dgx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2205238
Jan 03, 2024 - Investors are optimistic about Quest Diagnostics (DGX) on strength in base business and strategic collaborations.
0